Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
14
Number of overlapping holdings
10.3%
% of XBI's 136 holdings also in IBRN
34.1%
% of IBRN's 55 holdings also in XBI
Overlap by Weight
Sector Drift (XBI minus IBRN)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in IBRN |
Overlap | |
|---|---|---|---|---|
 |
NEUROCRINE BIOSCIENCES INC | 2.8% | 4.3% | 2.8% |
|
SAREPTA THERAPEUTICS INC | 2.7% | 3.9% | 2.7% |
|
BIOGEN IDEC INC | 2.1% | 3.0% | 2.1% |
 |
ALKERMES PLC | 1.2% | 4.6% | 1.2% |
|
ACADIA PHARMACEUTICALS INC | 0.8% | 4.4% | 0.8% |
Position Highlights (Non-Overlapping Exposures)
XBI Overweight Relative to IBRN
|
NATERA INC | 3.5% |
|
GILEAD SCIENCES INC | 3.0% |
|
INCYTE CORP | 2.9% |
|
UNITED THERAPEUTICS CORP | 2.9% |
|
ADVENTRX PHARMACEUTICALS INC | 2.8% |
|
INSMED INC | 2.6% |
|
VERTEX PHARMACEUTICALS INC | 2.6% |
|
EXACT SCIENCES CORP | 2.5% |
|
ALNYLAM PHARMACEUTICALS INC | 2.5% |
|
ABBVIE INC | 2.4% |
XBI Underweight Relative to IBRN
|
PTC THERAPEUTICS INC | -5.2% |
|
SCHOLAR ROCK HOLDING CORP. | -4.7% |
|
INTRA-CELLULAR THERAPIES INC | -4.6% |
 |
ARGENX SE ADR | -4.5% |
|
CATALYST PHARMACEUTICAL PART | -4.0% |
 |
SK BIOPHARMACEUTICALS CO., LTD. | -3.8% |
|
SUPERNUS PHARMACEUTICALS INC | -3.8% |
|
ACADIA PHARMACEUTICALS INC | -3.6% |
|
ALKERMES PLC | -3.4% |
|
EDGEWISE THERAPEUTICS, INC. | -3.2% |